raising the bar in her2-positive breast cancer
Published 8 years ago • 7.5K plays • Length 32:54Download video MP4
Download video MP3
Similar videos
-
1:09:24
raising the bar in hr /her2- early breast cancer: cdk4 and 6 inhibitors
-
1:31:37
personalizing treatment decisions in her2-altered breast cancer
-
1:03:59
selecting and sequencing of her2-targeting therapies in her2-positive metastatic breast cancer
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
29:15
everything i ate today as a breast cancer patient. breast cancer vlog -pia besmonte
-
57:03
ask the expert: early-stage hormone receptor-positive, her2-positive & triple-positive breast cancer
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
1:25:12
a guide for selection, sequencing, and optimal use of her2-targeted therapies in her2 breast cancer
-
7:44
treatment options for her2 breast cancer: a comprehensive guide
-
1:35:31
leveraging targeted therapies to improve outcomes across the continuum of her2 breast cancer
-
22:12
how to treat her2 breast cancer in 2024 with dr. harold burstein
-
0:58
treatment approach for metastatic her2 positive breast cancer
-
57:18
navigating the expanding treatment arsenal for er /her2- breast cancer
-
59:12
making precision decisions in high-risk hr , her2- metastatic breast cancer
-
1:02:48
expanding treatment options in er /her2- breast cancer: serds, serms, sercas, and more
-
1:25:22
a new view of the spectrum of her2 expression and significance of her2 low in breast cancer
-
1:40:47
clarifyingcomplexities of expandingtreatmentoptionsfor advancedandearly-stage hr /her2- breastcancer
-
4:25
new breast cancer vaccine for her2 positive patients || dr liz o'riordan
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
5:45
her2-positive breast cancer: a paradigm shift in diagnosis and therapy
-
1:24:52
guiding multifactorial clinical decisions in hr , her2- breast cancer
-
1:00
2nd line treatment options for hr breast cancer.